Clinical Trials Browser

Phase 1 × OTHER × sotrovimab × Clear all

NCT05135650 2025-02-13

Pharmacokinetics of Sotrovimab as Pre-exposure Prophylaxis for COVID-19 in Hematopoietic Stem Cell Transplant Recipients, COVIDMAB Study

Phase 1 Terminated

20 enrolled 17 charts

Other hematologic neoplasm

COVID-19, Hematologic Neoplasms